Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability
暂无分享,去创建一个
B. Hesse | L. Opie | B. Hesse | L. H. Opie
[1] R. Bolli,et al. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. , 1996, Journal of molecular and cellular cardiology.
[2] S L Bacharach,et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.
[3] Y. Yonekura,et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] S. Rahimtoola,et al. The hibernating myocardium. , 1989, American heart journal.
[5] M. Phelps,et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.
[6] E. Fallen,et al. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? , 1997, Journal of the American College of Cardiology.
[7] Y. Yonekura,et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. , 1989, The American journal of cardiology.
[8] U. Ruotsalainen,et al. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. , 1994, The American journal of physiology.
[9] B. Gerber,et al. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. , 1997, The Journal of thoracic and cardiovascular surgery.
[10] H. Schelbert,et al. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. , 1996, Circulation.
[11] A. Nunn,et al. Nitroimidazoles for imaging hypoxic myocardium , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[12] D. Miller. The growing flood of technetium-99m myocardial perfusion agents. More water ... or more mud? , 1995, Circulation.
[13] M P Sandler,et al. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] R O Bonow,et al. Identification of viable myocardium. , 1996, Circulation.
[15] C. Stone,et al. Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. , 1992, The American journal of physiology.
[16] L. Opie,et al. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. , 1989, Progress in cardiovascular diseases.
[17] M. Schwaiger,et al. The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] M Schwaiger,et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.
[19] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[20] A Bol,et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. , 1996, Circulation.
[21] J J Bax,et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. , 1996, Journal of the American College of Cardiology.
[22] Y. Yonekura,et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction , 1996, European Journal of Nuclear Medicine.
[23] J. Balschi,et al. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. , 1996, Circulation.
[24] A. Arai,et al. Metabolic adaptation to a gradual reduction in myocardial blood flow. , 1995, Circulation.
[25] R. Sh. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. , 1985, Circulation.
[26] H. Nick,et al. Regulation of annexin I in adipogenesis: cAMP-independent action of methylisobutylxanthine. , 1992, The American journal of physiology.
[27] G. Johnson,et al. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. , 1997, Circulation.
[28] M. Schwaiger,et al. Myocardial Glucose Uptake in Patients With Insulin‐Dependent Diabetes Mellitus Assessed Quantitatively by Dynamic Positron Emission Tomography , 1993, Circulation.
[29] H. Taegtmeyer,et al. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. , 1995, Circulation.
[30] S. Vatner,et al. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? , 1995, Circulation research.
[31] S. Rahimtoola. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. , 1996, Circulation.
[32] P. Nuutila,et al. The effect of insulin and FFA on myocardial glucose uptake. , 1995, Journal of molecular and cellular cardiology.
[33] A. Bol,et al. Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.
[34] K. Krohn,et al. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] L. Opie,et al. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. , 1990, Circulation research.
[36] G. Radda,et al. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87Rb NMR spectroscopic study , 1995, Magnetic resonance in medicine.
[37] J. Flack,et al. Benefits of adherence to anti-hypertensive drug therapy. , 1996, European heart journal.
[38] H. Schelbert,et al. Myocardial viability: methods of assessment and clinical relevance. , 1996, American heart journal.
[39] J. Canty,et al. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. , 1997, Circulation.
[40] L. Opie,et al. Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. , 1995, Journal of molecular and cellular cardiology.
[41] J. Kronauge,et al. Divergent Kinetics of 201TI and 99mTc‐SESTAI4IBI in Cultured Chick Ventricular Myocytes During ATP Depletion , 1992, Circulation.
[42] P. McLaughlin,et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? , 1990, Circulation.
[43] J. Vanoverschelde,et al. Chronic myocardial hibernation in humans. From bedside to bench. , 1997, Circulation.
[44] R. Gropler,et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. , 1993, Journal of the American College of Cardiology.
[45] L. Opie. Reperfusion injury and its pharmacologic modification. , 1989, Circulation.
[46] L. Opie. Metabolism of the heart in health and disease. Part I , 1968 .
[47] R. Brunken,et al. Present assessment of myocardial viability by nuclear imaging. , 1996, Seminars in nuclear medicine.
[48] S. Rahimtoola. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. , 1985, Circulation.
[49] G. Diamond,et al. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. , 1978, American heart journal.
[50] J. Ferguson,et al. Meeting Highlights American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996 , 1996 .
[51] R. Bonow. Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction , 1993 .
[52] P. Camici,et al. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. , 1996, Circulation.
[53] D. Hearse. Stunning: A radical re-view , 1991, Cardiovascular Drugs and Therapy.
[54] D. Miller,et al. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. , 1988, Circulation research.
[55] H. Schelbert. Different roads to the assessment of myocardial viability. Lessons from PET for SPECT. , 1995, Circulation.
[56] D. Hearse. Myocardial ischaemia: can we agree on a definition for the 21st century? , 1994, Cardiovascular research.
[57] BharatiShivalkar,et al. Only Hibernating Myocardium Invariably Shows Early Recovery After Coronary Revascularization , 1996 .
[58] H. Iida,et al. Glucose uptake in the chronically dysfunctional but viable myocardium. , 1996, Circulation.